Company intelligence / Profile preview

Pulsecare Medical Technology

Shenzhen, Guangdong, Chinapulsecare.cn ↗

Ownership: Private
Development stage: Preclinical

Overview

Pulsecare Medical Technology develops advanced minimally invasive and non-invasive therapeutic devices based on proprietary multimodal energy platforms. Their lead product—nsPFA for cardiac electrophysiology—has shown satisfactory short-term clinical results. The pipeline also includes systems for renal denervation to treat hypertension and multi-modal tumor ablation. The company leverages deep technical expertise to rapidly develop industry-leading device platforms.

Therapeutic areas: OncologyCardiovascular
Modalities: Device
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on Pulsecare Medical Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pulsecare Medical Technology.

Explore the full profile